Notably, this applies to a compact module of cell cycle regulators, namely survivin, cyclin B1, Cdk1, Plk1, and Bub1, whose expression increased about 2-fold in tumor versus transgenic cells according to measured fold changes. The gene discussed is PLK1; the disease is neoplasm.